BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 32683533)

  • 1. Diosgenin inhibits proliferation and migration of ovarian cancer cells and induce apoptosis via upregulation of PTEN.
    Fang F; Zhang X; Fang Y
    Chem Biol Drug Des; 2024 Mar; 103(3):e14459. PubMed ID: 38538058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mocetinostat as a novel selective histone deacetylase (HDAC) inhibitor in the promotion of apoptosis in glioblastoma cell line C6 and T98G.
    Khathayer F; Mikael M
    Res Sq; 2024 Apr; ():. PubMed ID: 38645087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diosgenin improves post-myocardial infarction cardiac function via HAND2-induced angiogenesis.
    Liu X; Shen D; Liu L; Peng Y; Lu Q
    Biochem Biophys Res Commun; 2024 Jun; 712-713():149941. PubMed ID: 38643718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diosgenyl glucosamine conjugates increase pro-apoptotic and selective activities in cancer cell lines.
    Sergio Iván MM; María Luisa ES; Hugo LM; Jazmín Ciciolil HM; Jesús SR; Uriel Yair AS; Luis SS
    Biol Cell; 2024 Mar; 116(3):e2300052. PubMed ID: 38408271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noscapine and Apoptosis in Breast and Other Cancers.
    Calaf GM; Crispin LA; Quisbert-Valenzuela EO
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diosgenin: Recent Highlights on Pharmacology and Analytical Methodology.
    Jesus M; Martins AP; Gallardo E; Silvestre S
    J Anal Methods Chem; 2016; 2016():4156293. PubMed ID: 28116217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irradiated riboflavin over nonradiated one: Potent antimigratory, antiproliferative and cytotoxic effects on glioblastoma cells.
    Kacar S; Hacioglu C; Kar F
    J Cell Mol Med; 2024 Apr; 28(8):e18288. PubMed ID: 38597418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pH-Sensitive Prodrug Nanocarrier Based on Diosgenin for Doxorubicin Delivery to Efficiently Inhibit Tumor Metastasis.
    Wei Z; Wang H; Xin G; Zeng Z; Li S; Ming Y; Zhang X; Xing Z; Li L; Li Y; Zhang B; Zhang J; Niu H; Huang W
    Int J Nanomedicine; 2020; 15():6545-6560. PubMed ID: 32943867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Wild Yam Root (
    Mazzio E; Almalki A; Darling-Reed SF; Soliman KFA
    Cancer Genomics Proteomics; 2021; 18(6):735-755. PubMed ID: 34697066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases.
    Parama D; Boruah M; Yachna K; Rana V; Banik K; Harsha C; Thakur KK; Dutta U; Arya A; Mao X; Ahn KS; Kunnumakkara AB
    Life Sci; 2020 Nov; 260():118182. PubMed ID: 32781063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase Inhibition in the Treatment of Leukemia: A Comprehensive Review.
    Bartoszewska E; Molik K; Woźniak M; Choromańska A
    Antioxidants (Basel); 2024 Mar; 13(4):. PubMed ID: 38671875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroidal Saponins: Naturally Occurring Compounds as Inhibitors of the Hallmarks of Cancer.
    Bouabdallah S; Al-Maktoum A; Amin A
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting Angiogenesis by Anti-Cancer Saponins: From Phytochemistry to Cellular Signaling Pathways.
    Majnooni MB; Fakhri S; Ghanadian SM; Bahrami G; Mansouri K; Iranpanah A; Farzaei MH; Mojarrab M
    Metabolites; 2023 Feb; 13(3):. PubMed ID: 36984763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer Activity of Diosgenin and Its Molecular Mechanism.
    Ren QL; Wang Q; Zhang XQ; Wang M; Hu H; Tang JJ; Yang XT; Ran YH; Liu HH; Song ZX; Liu JG; Li XL
    Chin J Integr Med; 2023 Aug; 29(8):738-749. PubMed ID: 36940072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Notch signaling in gliomas: a potential landscape of actionable converging targets for combination approach in therapies resistance.
    D'Amico M; De Amicis F
    Cancer Drug Resist; 2022; 5(4):939-953. PubMed ID: 36627893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Diosgenin-Based Liposome Delivery System Combined with Doxorubicin for Liver Cancer Therapy.
    Chen L; Lan J; Li Z; Zeng R; Wang Y; Zhen L; Jin H; Ding Y; Zhang T
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Compounds in Glioblastoma Therapy: Preclinical Insights, Mechanistic Pathways, and Outlook.
    Zhai K; Siddiqui M; Abdellatif B; Liskova A; Kubatka P; Büsselberg D
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Characterization of Diosgenin Encapsulated Poly-ε-Caprolactone-Pluronic Nanoparticles and Its Effect on Brain Cancer Cells.
    Rabha B; Bharadwaj KK; Baishya D; Sarkar T; Edinur HA; Pati S
    Polymers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diosgenin as a Novel Alternative Therapy for Inhibition of Growth, Invasion, and Angiogenesis Abilities of Different Glioblastoma Cell Lines.
    Khathayer F; Ray SK
    Neurochem Res; 2020 Oct; 45(10):2336-2351. PubMed ID: 32683533
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.